Cargando…
Epigenetic DNA Modifications Upregulate SPRY2 in Human Colorectal Cancers
Conventional wisdom is that Sprouty2 (SPRY2), a suppressor of Receptor Tyrosine Kinase (RTK) signaling, functions as a tumor suppressor and is downregulated in many solid tumors. We reported, for the first time, that increased expression of SPRY2 augments cancer phenotype and Epithelial-Mesenchymal-...
Autores principales: | Stuckel, Alexei J., Zeng, Shuai, Lyu, Zhen, Zhang, Wei, Zhang, Xu, Dougherty, Urszula, Mustafi, Reba, Zhang, Qiong, Joshi, Trupti, Bissonnette, Marc, Choudhury, Samrat Roy, Khare, Sharad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534322/ https://www.ncbi.nlm.nih.gov/pubmed/34685612 http://dx.doi.org/10.3390/cells10102632 |
Ejemplares similares
-
Sprouty4 is epigenetically upregulated in human colorectal cancer
por: Stuckel, Alexei J., et al.
Publicado: (2022) -
Enhanced CXCR4 Expression Associates with Increased Gene Body 5-Hydroxymethylcytosine Modification but not Decreased Promoter Methylation in Colorectal Cancer
por: Stuckel, Alexei J., et al.
Publicado: (2020) -
Correction: Stuckel, et al.; Enhanced CXCR4 Expression Associates with Increased Gene Body 5-Hydroxymethylcytosine Modification but Not Decreased Promoter Methylation in Colorectal Cancer. Cancers 2020, 12, 539
por: Stuckel, Alexei J., et al.
Publicado: (2020) -
Sprouty-2 Controls c-Met Expression and Metastatic Potential of Colon Cancer Cells: Sprouty/c-Met Upregulation in Human Colonic Adenocarcinomas
por: Holgren, Cory, et al.
Publicado: (2010) -
CXCL12-CXCR4/CXCR7 Axis in Colorectal Cancer: Therapeutic Target in Preclinical and Clinical Studies
por: Khare, Tripti, et al.
Publicado: (2021)